Company / R&D per Share
Envista Holdings R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.70
FY2025
5-year range
$0.55 / $0.70
FY2021-FY2025
Trend
+20.9%
vs FY2024
Sector context
#80 of 109
Health Care
What the data says
At $0.70, Envista Holdings's r&d per share ranks #80 of 109 in the Health Care sector. R&D per Share has fluctuated over the past 9 years, ranging from $0.54 in FY2020 to $1331000.00 in FY2019.
Based on SEC 10-K filings.
0.70 in FY2025 with a 5-year CAGR of +5.1%.
Improved from $0.55 to $0.70 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- +5.1%
- 10-Year CAGR
- -
Sector benchmark
#80 of 109 in Health CareTop 73% of 109This company $0.70 Sector average $2.08
▼
-66.5% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 20.9% year-over-year.
- Ranks #80 out of 109 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.70 | +20.9% |
| FY2024 | $0.58 | +5.2% |
| FY2023 | $0.55 | -10.8% |
| FY2022 | $0.61 | -1.4% |
| FY2021 | $0.62 | +14.8% |
| FY2020 | $0.54 | -100.0% |
| FY2019 | $1331000.00 | +98973679.1% |
| FY2018 | $1.34 | -0.2% |
| FY2017 | $1.35 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026